期刊文献+

起搏器更换相关并发症的单中心分析 被引量:2

Complications associated with device replacement in China: a single center experience
原文传递
导出
摘要 目的回顾性分析阜外心血管病医院起搏器更换手术相关并发症的发生情况。方法分析2008年6月至2011年6月期间在阜外心血管病医院接受起搏器更换的714例患者。术后3、6、12个月时工作人员通过常规门诊随访或电话随访的方式进行随访,之后改为每年1次,并以电话随访方式进行非定期随访。通过术后定期门诊随访或电话随访了解患者并发症发生情况,平均随访(19.5±9.7)个月。所有与手术相关的并发症均纳人本次研究。结果随访期间共22例(3.1%)患者出现手术相关的并发症其中,13例(1.8%)出现次要并发症,包括4例起搏器囊袋血肿,2例起搏器移位,6例伤L]愈合4j良和1例局限性气胸;9例(1.3%)出现主要并发症,包括3例起搏导线脱位,3例严重的囊袋血肿,起搏器囊袋调整1例和2例严重的感染。9例主要并发症患者均接受了再次手术。接受起搏器导线相关操作的患者并发症发生率有增高的趋势。服用抗凝和抗血小板药物并不增加患者术后并发症的风险。结论尽管由经验丰富的医师进行操作能够降低起搏器更换的并发症发生率,但手术操作仍存在不能忽略的风险。我国植入型心律转复除颤器和心脏再同步治疗起搏器的更换数量较少,对此类起搏器更换术后的并发症情况仍需要进一步观察。 Objective To evaluate the complication rates associated with device replacement in Fuwai hospital. Methods Seven hundred and fourteen patients underwent device replacement in Fuwai hospital from June 1 - 2008 to June 1 - 2011 were involved. Patients were conventionally received an out-patient follow-up in 3,6 and 12 months, after that, once a year. The mean follow-up time was ( 19.5 ±9. 7) months. Complications associated with operation were counted. Results Complications occurred in a total of 22 patients(3. 1% ). There were 13 minor complications ( 1.8 % ) includeded : hematoma ( n = 4 ), device migration ( n = 2 ), incisional dehis- cence ( n = 6) and limited pneumothorax ( n = 1 ). There were 9 major complications ( 1.3 % ) includeded :lead dis- location( n= 3 ),hematoma( n = 3 ), pocket revision (n = 1 )and infections requiring system removal in two pa- tients. There was no significant difference in the complication rate between patients with and without leads oper- ation. Anticoagulation therapy and anti-platelet therapy did not increase the risk of complications. Conclusions Device replacements performed in a center with enough experience demonstrated a low but not negligible risk of complications. The complications related to implantable cardioverter defibrillator(ICD) and cardiac resynchroni- zation therapy(CRTP/D) replacement need further invetigation.
出处 《中华心律失常学杂志》 2012年第3期172-175,共4页 Chinese Journal of Cardiac Arrhythmias
关键词 起搏器 更换 并发症 Pacemaker Replacement Complications
  • 相关文献

参考文献15

  • 1Uslan DZ, Sohail MR, St Sauver JL, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a populationbased study. Arch Intern Med,2007,167 : 669-675.
  • 2Klug D, Balde M, Pavin D, et al. PEOPLE Study Group. Risk factors related to infections of implanted pacemakers and cardioverter- defibrillators: results of a large prospective study. Circulation, 2007,116:1349-1355.
  • 3Poole JE, Gleva M J, Mela T, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures results from the REPLACE registry. Circulation ,2010,122 : 1553-1561.
  • 4Costea A, Rardon DP, Padanilam B.f, et al. Complications associated with generator replacement in response to device advisories. J Cardiovasc Electrophysiol,2008 ,19 :266-269.
  • 5Moore JW3 rd, Barrington W, Bazaz R, et al. Complications of replacing implantable devices in response to advisories:A single center experience. In J Cardio1,2009 : 134:42-46.
  • 6Harcombe AA, Newell SA, Ludman PF, et al. Late complications following permanent pacemaker implantation or elective unit replacement. Heart, 1998,80:240-244.
  • 7Takahashi T, Bhandari AK, Watanuki M, et al. High incidence of device-related and lead-related complications in the dual-chamber implantable cardioverter defibrillator compared with the single- chamber version. Circ J,2002,66:746-750.
  • 8Duray GZ, Schmitt J, Cicek-Hartvig S, et al. Complications leading to surgical revision in implantable cardioverter defibrillator patients : comparison of patients with single-chamber, dualchamber, and biventricular devices. Europace,2009,11:297-302.
  • 9Lee DS, Krahn AD, Healey JS, et al. Evaluation of early complications related to de novo cardioverter defibrillator implantation : insights from the Ontario ICD database. J Am Coll Cardiol,2010,55 : 774-782.
  • 10Kapa S, Hyberger L, Rea RF, et al. Complication risk with pulse generator change:implications when reacting to a device advisory or recall. Pacing Clin Electrophysiol,2007 ,30 :730-733.

二级参考文献13

  • 1张建军,杨新春,胡大一,商丽华,汪爱虎,陈明.462例永久起搏器置入术并发症的相关因素分析及防治对策[J].中国心脏起搏与心电生理杂志,2004,18(6):456-457. 被引量:64
  • 2冯义柏.心脏起搏器植入技术指南[J].中华心律失常学杂志,1998,2(3):217-224. 被引量:31
  • 3Klug D,Balde M,Pavin D,et al.Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators:results of a large prospective study.Circulation,2007,116:1349-1355.
  • 4Poole JE,Gleva M J,Mela T,et al.Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures:results from the REPLACE registry.Circulation,2010,122:1553-1561.
  • 5Vardas PE,Auricchio A,Blanc JJ,et al.Guidelines for cardiac pacing and cardiac resynchronization therapy:the task force for cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology.Developed in collaboration with the European Heart Rhythm Association.Eur Heart J,2007,28:2256-2295.
  • 6Tompkins C,Cheng A,Dalal D,et al.Dual antiplatelet therapy and heparin “bridging” significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.J Am Coll Cardio1,2010,55:2376-2382.
  • 7Chow V,Ranasinghe I,Lau J,et al.Peri-procedural anticoagulation and the incidence of haematoma formation after permanent pacemaker implantation in the elderly.Heart Lung Circ,2010,19:706-712.
  • 8Ellenbogen KA,Hellkamp AS,Wilkoff BL,et al.Complications arising after implantation of DDD pacemakers:the MOST experience.Am J Cardiol,2003,92:740-741.
  • 9Sohail MR,Uslan DZ,Khan AH,et al.Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections.J Am Coll Cardio1,2007,49:1851-1859.
  • 10Chu VH,Crosslin DR,Friedman JY,et al.Staphylococcus aureus bacteremia in patients with prosthetic devices:costs and outcomes.Am J Med,2005,118:e19-e24.

共引文献37

同被引文献21

  • 1Authors/Task Force Members,McMurray JJ, Adamopoulos S,et al [DB/OL]. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart FaiLure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J ,2012. [ 2012-06-02 ]. http://eurheartj, oxfordjoumals org/content/early/2012/05/17/eurheartj.
  • 2Oginosawa Y, Abe H, Nakashima Y, The incidence and risk factors for venous obstruction after implantation of transvenous pacing leads. Pacing Clin Electrophysiol,2002,25:1605-1611.
  • 3Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coil Cardiol, 2006, 48: 590-591.
  • 4Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation,2010, 121:458-477.
  • 5Margey R, McCann H, Blake G, et al. Contemporary management of and outcomes from cardiac device related infections. Europace, 2010, 12: 64-70.
  • 6Mond HG,Irwin M,Ector H,et al.The world survey of cardiac pa- cing and :calendar year 2005 an Interna- tional Cardiac Pacing and Electrophysiology Society (ICPES) pro- ject [ J ].Pacing Clin EIectmphysiol, 2008,31 : 1202-1212.
  • 7Brignole M, Auriechio A,Baron-Esquivias G,et al.2013 ESC Guide- lines on cardiac pacing and cardiac resynchronization therapy:the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC).Developed in collaboration with the European Heart Rhythm Association ( EHRA ) [ J ]. Eur Heart J, 2013,34 : 2281 - 2329.
  • 8Zhan C, Baine WB, Sedrakyan A, et al.Cardiac device implantation in the United States from 1997 through 2004 : a population-based analysis[J] .J Gen Intern Med,2008,23:13-19.
  • 9Reynolds MR, Cohen DJ, Kugelmass AD, et al.The frequency and incremental cost of major complications among medicare beneficia- ries receiving implantable cardioverter-defibrillators [J] .J Am Coll Cardiol, 2006,47 : 2493- 2497.
  • 10A1-Khatib SM, Lucas FL, Jollis JG, et al. The relation between pa- tients' outcomes and the volume of cardioverter-defibrillator im- plantation procedures performed by physicians treating medicare beneficiaries [ J ] .J Am Coil Cardiol,2005,46 : 1536-1540.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部